Annual CFF
$9.64 M
+$10.27 M+1636.92%
December 31, 2023
Summary
- As of March 13, 2025, SMTI annual cash flow from financing activities is $9.64 million, with the most recent change of +$10.27 million (+1636.92%) on December 31, 2023.
- During the last 3 years, SMTI annual CFF has risen by +$9.02 million (+1449.27%).
- SMTI annual CFF is now -65.93% below its all-time high of $28.30 million, reached on December 31, 2021.
Performance
SMTI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$14.43 M
+$9.64 M+201.15%
September 30, 2024
Summary
- As of March 13, 2025, SMTI quarterly cash flow from financing activities is $14.43 million, with the most recent change of +$9.64 million (+201.15%) on September 30, 2024.
- Over the past year, SMTI quarterly CFF has increased by +$5.21 million (+56.47%).
- SMTI quarterly CFF is now -49.78% below its all-time high of $28.74 million, reached on March 31, 2021.
Performance
SMTI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$18.38 M
+$5.21 M+39.54%
September 30, 2024
Summary
- As of March 13, 2025, SMTI TTM cash flow from financing activities is $18.38 million, with the most recent change of +$5.21 million (+39.54%) on September 30, 2024.
- Over the past year, SMTI TTM CFF has increased by +$8.86 million (+93.03%).
- SMTI TTM CFF is now -37.40% below its all-time high of $29.36 million, reached on March 31, 2021.
Performance
SMTI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SMTI Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +1636.9% | +56.5% | +93.0% |
3 y3 years | +1449.3% | +2749.1% | +6068.3% |
5 y5 years | +100.0% | +2749.1% | +6068.3% |
SMTI Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -65.9% | +1636.9% | at high | +2290.9% | -35.0% | +2501.6% |
5 y | 5-year | -65.9% | +1636.9% | -49.8% | +2290.9% | -37.4% | +2501.6% |
alltime | all time | -65.9% | +1636.9% | -49.8% | +1772.3% | -37.4% | +2501.6% |
Sanara MedTech Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $14.43 M(+201.1%) | $18.38 M(+39.5%) |
Jun 2024 | - | $4.79 M(-827.5%) | $13.17 M(+48.2%) |
Mar 2024 | - | -$658.80 K(+254.4%) | $8.89 M(-7.8%) |
Dec 2023 | $9.64 M(-1636.9%) | -$185.90 K(-102.0%) | $9.64 M(+1.2%) |
Sep 2023 | - | $9.22 M(+1720.9%) | $9.52 M(+3095.5%) |
Jun 2023 | - | $506.60 K(+428.8%) | $298.00 K(-169.5%) |
Mar 2023 | - | $95.80 K(-131.5%) | -$428.60 K(-31.7%) |
Dec 2022 | -$627.30 K(-102.2%) | -$304.40 K(<-9900.0%) | -$627.30 K(-18.0%) |
Sep 2022 | - | $0.00(-100.0%) | -$765.40 K(0.0%) |
Jun 2022 | - | -$220.00 K(+113.8%) | -$765.40 K(+40.3%) |
Mar 2022 | - | -$102.90 K(-76.7%) | -$545.40 K(-101.9%) |
Dec 2021 | $28.30 M(+4447.1%) | -$442.50 K(<-9900.0%) | $28.30 M(-1.6%) |
Sep 2021 | - | $0.00(0.0%) | $28.75 M(-0.1%) |
Jun 2021 | - | $0.00(-100.0%) | $28.78 M(-2.0%) |
Mar 2021 | - | $28.74 M(>+9900.0%) | $29.36 M(+4618.2%) |
Dec 2020 | $622.30 K(-93.7%) | $13.10 K(-50.0%) | $622.30 K(-92.6%) |
Sep 2020 | - | $26.20 K(-95.5%) | $8.41 M(-10.4%) |
Jun 2020 | - | $583.00 K(>+9900.0%) | $9.38 M(+0.9%) |
Mar 2020 | - | $0.00(-100.0%) | $9.30 M(-5.1%) |
Dec 2019 | $9.80 M(>+9900.0%) | $7.80 M(+680.0%) | $9.80 M(+390.0%) |
Sep 2019 | - | $1.00 M(+100.0%) | $2.00 M(+100.0%) |
Jun 2019 | - | $500.00 K(0.0%) | $1.00 M(+100.0%) |
Mar 2019 | - | $500.00 K(>+9900.0%) | $500.00 K(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
Sep 2018 | - | $0.00(0.0%) | -$300.00(-78.6%) |
Jun 2018 | - | $0.00(0.0%) | -$1400.00(-98.8%) |
Mar 2018 | - | $0.00(-100.0%) | -$120.60 K(-16.5%) |
Dec 2017 | -$144.60 K(-159.0%) | -$300.00(-72.7%) | -$144.50 K(-16.5%) |
Sep 2017 | - | -$1100.00(-99.1%) | -$173.00 K(-22.8%) |
Jun 2017 | - | -$119.20 K(+398.7%) | -$224.00 K(+1225.4%) |
Mar 2017 | - | -$23.90 K(-17.0%) | -$16.90 K(-106.9%) |
Dec 2016 | $244.90 K(-71.8%) | -$28.80 K(-44.7%) | $244.90 K(-46.8%) |
Sep 2016 | - | -$52.10 K(-159.3%) | $460.60 K(-38.6%) |
Jun 2016 | - | $87.90 K(-63.1%) | $749.80 K(-32.3%) |
Mar 2016 | - | $237.90 K(+27.3%) | $1.11 M(+27.7%) |
Dec 2015 | $867.10 K(-60.1%) | $186.90 K(-21.2%) | $867.10 K(+29.6%) |
Sep 2015 | - | $237.10 K(-46.7%) | $669.30 K(+55.2%) |
Jun 2015 | - | $445.10 K(<-9900.0%) | $431.30 K(+160.1%) |
Mar 2015 | - | -$2000.00(-81.7%) | $165.80 K(-92.4%) |
Dec 2014 | $2.17 M(+17.5%) | -$10.90 K(+1111.1%) | $2.17 M(-21.4%) |
Sep 2014 | - | -$900.00(-100.5%) | $2.77 M(-4.2%) |
Jun 2014 | - | $179.60 K(-91.0%) | $2.89 M(-0.2%) |
Mar 2014 | - | $2.01 M(+245.8%) | $2.89 M(+56.3%) |
Dec 2013 | $1.85 M | $580.10 K(+377.8%) | $1.85 M(+51.6%) |
Sep 2013 | - | $121.40 K(-34.5%) | $1.22 M(-21.8%) |
Jun 2013 | - | $185.40 K(-80.8%) | $1.56 M(-1.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2013 | - | $963.70 K(-2039.0%) | $1.58 M(+76.0%) |
Dec 2012 | $896.60 K(-45.1%) | -$49.70 K(-110.8%) | $896.50 K(-9.1%) |
Sep 2012 | - | $461.80 K(+128.7%) | $986.10 K(-391.1%) |
Jun 2012 | - | $201.90 K(-28.5%) | -$338.80 K(-188.4%) |
Mar 2012 | - | $282.50 K(+608.0%) | $383.20 K(-76.5%) |
Dec 2011 | $1.63 M(-7.2%) | $39.90 K(-104.6%) | $1.63 M(+13.0%) |
Sep 2011 | - | -$863.10 K(-193.4%) | $1.44 M(-49.1%) |
Jun 2011 | - | $923.90 K(-39.7%) | $2.84 M(-0.1%) |
Mar 2011 | - | $1.53 M(-1131.6%) | $2.84 M(+61.5%) |
Dec 2010 | $1.76 M(+36.4%) | -$148.50 K(-128.0%) | $1.76 M(-26.5%) |
Sep 2010 | - | $530.50 K(-42.8%) | $2.39 M(+16.0%) |
Jun 2010 | - | $927.30 K(+106.1%) | $2.06 M(+70.0%) |
Mar 2010 | - | $449.90 K(-7.1%) | $1.21 M(-6.0%) |
Dec 2009 | $1.29 M(-16.0%) | $484.20 K(+141.5%) | $1.29 M(+39.4%) |
Sep 2009 | - | $200.50 K(+157.1%) | $925.50 K(+13.5%) |
Jun 2009 | - | $78.00 K(-85.2%) | $815.30 K(-4.2%) |
Mar 2009 | - | $527.10 K(+339.6%) | $850.70 K(-44.6%) |
Dec 2008 | $1.54 M(+576.5%) | $119.90 K(+32.8%) | $1.54 M(-1.2%) |
Sep 2008 | - | $90.30 K(-20.4%) | $1.55 M(+6.0%) |
Jun 2008 | - | $113.40 K(-90.6%) | $1.47 M(+3.1%) |
Mar 2008 | - | $1.21 M(+774.5%) | $1.42 M(+526.3%) |
Dec 2007 | $227.00 K(-65.0%) | $138.60 K(+6200.0%) | $227.00 K(-44.5%) |
Sep 2007 | - | $2200.00(-96.8%) | $408.90 K(-17.8%) |
Jun 2007 | - | $68.80 K(+295.4%) | $497.50 K(-15.2%) |
Mar 2007 | - | $17.40 K(-94.6%) | $586.80 K(-9.6%) |
Dec 2006 | $648.90 K(+2.8%) | $320.50 K(+253.0%) | $648.90 K(+40.9%) |
Sep 2006 | - | $90.80 K(-42.6%) | $460.60 K(+3.4%) |
Jun 2006 | - | $158.10 K(+98.9%) | $445.60 K(+13.2%) |
Mar 2006 | - | $79.50 K(-39.9%) | $393.80 K(-37.6%) |
Dec 2005 | $631.40 K(-36.9%) | $132.20 K(+74.4%) | $631.30 K(+11.5%) |
Sep 2005 | - | $75.80 K(-28.7%) | $566.10 K(-51.7%) |
Jun 2005 | - | $106.30 K(-66.5%) | $1.17 M(-2.3%) |
Mar 2005 | - | $317.00 K(+373.1%) | $1.20 M(+19.9%) |
Dec 2004 | $1.00 M(+32.1%) | $67.00 K(-90.2%) | $1.00 M(+7.2%) |
Sep 2004 | - | $682.30 K(+411.5%) | $933.50 K(+271.6%) |
Jun 2004 | - | $133.40 K(+13.2%) | $251.20 K(+113.2%) |
Mar 2004 | - | $117.80 K(-73.3%) | $117.80 K(-89.2%) |
Mar 2002 | - | $440.70 K(+119.3%) | $1.09 M(+44.1%) |
Dec 2001 | $757.40 K(+28.8%) | $201.00 K(-25.4%) | $757.50 K(+13.9%) |
Sep 2001 | - | $269.40 K(+49.2%) | $665.00 K(+35.0%) |
Jun 2001 | - | $180.60 K(+69.6%) | $492.60 K(-14.3%) |
Mar 2001 | - | $106.50 K(-1.8%) | $574.50 K(-2.3%) |
Dec 2000 | $588.20 K(+950.4%) | $108.50 K(+11.9%) | $588.20 K(+22.6%) |
Sep 2000 | - | $97.00 K(-63.0%) | $479.70 K(+25.3%) |
Jun 2000 | - | $262.50 K(+118.4%) | $382.70 K(+218.4%) |
Mar 2000 | - | $120.20 K | $120.20 K |
Dec 1999 | $56.00 K | - | - |
FAQ
- What is Sanara MedTech annual cash flow from financing activities?
- What is the all time high annual CFF for Sanara MedTech?
- What is Sanara MedTech annual CFF year-on-year change?
- What is Sanara MedTech quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Sanara MedTech?
- What is Sanara MedTech quarterly CFF year-on-year change?
- What is Sanara MedTech TTM cash flow from financing activities?
- What is the all time high TTM CFF for Sanara MedTech?
- What is Sanara MedTech TTM CFF year-on-year change?
What is Sanara MedTech annual cash flow from financing activities?
The current annual CFF of SMTI is $9.64 M
What is the all time high annual CFF for Sanara MedTech?
Sanara MedTech all-time high annual cash flow from financing activities is $28.30 M
What is Sanara MedTech annual CFF year-on-year change?
Over the past year, SMTI annual cash flow from financing activities has changed by +$10.27 M (+1636.92%)
What is Sanara MedTech quarterly cash flow from financing activities?
The current quarterly CFF of SMTI is $14.43 M
What is the all time high quarterly CFF for Sanara MedTech?
Sanara MedTech all-time high quarterly cash flow from financing activities is $28.74 M
What is Sanara MedTech quarterly CFF year-on-year change?
Over the past year, SMTI quarterly cash flow from financing activities has changed by +$5.21 M (+56.47%)
What is Sanara MedTech TTM cash flow from financing activities?
The current TTM CFF of SMTI is $18.38 M
What is the all time high TTM CFF for Sanara MedTech?
Sanara MedTech all-time high TTM cash flow from financing activities is $29.36 M
What is Sanara MedTech TTM CFF year-on-year change?
Over the past year, SMTI TTM cash flow from financing activities has changed by +$8.86 M (+93.03%)